authors
- Hebert, PC
- Fergusson, DA
- Hutton, B
- Mazer, CD
- Fremes, S
- Blajchman, Morris
- MacAdams, C
- Wells, G
- Robblee, J
- Bussieres, J
- Teoh, K
Regulatory decisions pertaining to aprotinin may be putting patients at risk
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 9, 2014
has subject area
- 11 Medical and Health Sciences (FoR)
- Antifibrinolytic Agents (MeSH)
- Aprotinin (MeSH)
- Canada (MeSH)
- Clinical Trials as Topic (MeSH)
- Drug Approval (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Risk (MeSH)
published in
- CMAJ Journal